To Get Help Now
Click Here
 
Today's Date:

Avandia To Be Available Only Through Special Program

AddThis Social Bookmark Button

Diabetes drug Avandia and combination drugs containing rosiglitazone will only be available through a special program after it is pulled from all U.S. pharmacies starting November 18, 2011, and only to patients who are already taking the drug successfully and who are unable to control their diabetes with other drugs.

Avandia, manufactured by GlaxoSmithKline Plc., was the best selling diabetes drug in the world, generating more than $680 million in sales last year. However,  data has shown that patients who use Avandia and other rosiglitazone-containing medicines like Avandamet, and Avandaryl, have an increased risk of heart attack.

The Food and Drug Administration said in a safety announcement posted on its website that they are significantly restricting access to the diabetes drug Avandia, and that “Healthcare providers and patients must be enrolled in the Avandia-rosiglitazone Medicines Access Program in order to prescribe and receive rosiglitazone medicines. ” Type 2 diabetics and physicians who wish to continue using or prescribing Avandia will need to enroll in  special program and will receive the medication through mail order from specially certified pharmacies.

A GlaxoSmithKline spokeswoman said that the company will begin telling pharmacies and physicians about the program within 60 days and will implement changes during that time. She recommends that patients who are currently taking Avandia and other rosiglitazone-containing medicines should talk with their doctors before stopping the medication.

 

 

 

breakinglawsuitnews.com disclaimer: This article: Avandia To Be Available Only Through Special Program was posted on Thursday, May 19th, 2011 at 6:37 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.